Experimental validation of drug responses predicted by deep learning-based bioactivity models in hepatocellular carcinoma cell lines

Download

HIBIT22_paper_33.pdf

Date

2022-10

Author

Akar, Etkin
Ozcan, Umut Onur
Mohammadvand, Navid
Doğan, Tunca
Kahraman, Deniz Cansen

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

169
views

46
downloads

Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide. Although it has high mortality rate, there are currently few drugs available as treatment options. Therefore, there is an urgent need for intensive basic research and clinical trials in HCC. With the utilization of computational predictive approaches, effective treatment strategies, which leverage target-based drug response predictions, can be developed. This study aims to validate the results of deep learning-based prediction method, DeepResponse, developed by “Biological Data Science Lab” at Hacettepe University, and propose small molecule inhibitors that are active against HCC cell lines.

URI

https://hibit2022.ims.metu.edu.tr
https://hdl.handle.net/11511/101993

Conference Name

The International Symposium on Health Informatics and Bioinformatics

Collections

Graduate School of Informatics, Conference / Seminar

Suggestions

OpenMETU
Core

Network-based discovery of molecular targeted agent treatments in hepatocellular carcinoma Fayetörbay, Rumeys; Tunçbağ, Nurcan; Department of Bioinformatics (2020) Hepatocellular carcinoma (HCC) is one of the most-deadly cancers and the most common type of primary liver cancer. Multikinase inhibitor Sorafenib is one of FDA approved targeted agents in HCC treatment. PI3K/AKT/mTOR pathway is altered in about 51% of HCC; hence, understanding how Sorafenib and PI3K/AKT/mTOR pathway inhibitors act at signaling level is crucial for targeted therapies and to reveal the off-target effects. In this work, we use gene expression profiles (GEPs) of HCC cells (Huh7 and Mahlavu) wh...
In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma Sinoplu, Esra; Tunçbağ, Nurcan; Kahraman, Deniz C.; Atalay, Rengül (2019-07-01) Hepatocellular carcinoma (HCC) is the 5th most common and 2nd deadliest cancer worldwide. The molecular mechanism in HCC involves activated cell survival pathways, but there is a lack of the significant oncogenic drivers for targeted therapies. Thus, novel drugs and targets that can be exploited, are required. The pathways reported to be involved in hepatocarcinogenesis were retrieved from KEGG database (HCC, MAPK, calcium, p53, PI3K-Akt, Wnt, TGF-B, NAFLD and apoptosis) and a directed network with 801 node...
Characterization of liposomal celecoxib formulation as a drug delivery system in colorectal cancer cell lines Erdoğ, Aslı; Banerjee, Sreeparna; Department of Biotechnology (2012) Colorectal carcinoma (CRC) is one of the most common cancers and is the leading cause of cancer deaths in much of the developed world. Owing to the high incidence of drug resistance and potential toxic effects of chemotherapy drugs, much research is currently underway to design better strategies for smart drug delivery systems. Cyclooxygenase-2 (COX-2) pathway is associated with poor prognosis in colon carcinomas. The selective COX-2 inhibitor drug Celecoxib (CLX) has been shown to posses COX-2 independent ...
Structural mapping and network analysis of patient-specific mutations in glioblastoma Kaya, Tuğba; Tunçbağ, Nurcan; Doğan, Tunca; Department of Bioinformatics (2018) Cancer is one of the most common cause of death worldwide. It occurs as a result of a collection of somatic deviations from normal state. Therefore, many efforts have been invested to profile mutations in different types of tumors; such as, the Cancer Genome Atlas (TCGA) which deposits multiple omic data for more than 11,000 tumor samples. In this thesis, we present a pipeline which retrieves patient-specific mutation data in Glioblastoma from TCGA, maps these mutations on the protein structures in Protein ...
Molecular Biology of Liver Cancer Tulin, Ersahin; Öztürk, Mehmet; Atalay, Rengül (2015-01-01) Hepatocellular carcinoma (HCC) is one of the leading causes of cancer‐related mortality worldwide. Recent advances in the molecular profiling of HCC emphasize its intratumoral heterogeneity and reveal how cellular pathways are altered in favor of tumor progression. Malignant transformation of primary liver cancer is achieved through the acquisition of cancer hallmark capabilities that promote the uncontrolled proliferation of hepatocytes. In this review, the characteristics and acquired capabilities of huma...

Citation Formats

E. Akar, U. O. Ozcan, N. Mohammadvand, T. Doğan, and D. C. Kahraman, “Experimental validation of drug responses predicted by deep learning-based bioactivity models in hepatocellular carcinoma cell lines,” Erdemli, Mersin, TÜRKİYE, 2022, p. 3033, Accessed: 00, 2023. [Online]. Available: https://hibit2022.ims.metu.edu.tr.